Research Papers

21 of 121 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
The Obese Brain--Effects of Bariatric Surgery on Energy Balance Neurocircuitry.
de Lima-Júnior JC; Velloso LA; Geloneze B.
Curr Atheroscler Rep (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Sex differences in the pathophysiology, treatment, and outcomes in IHD.
Sanghavi M; Gulati M.
Curr Atheroscler Rep (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Renal artery stenosis-when to screen, what to stent?
Jennings CG; Houston JG; Severn A; Bell S; Mackenzie IS; Macdonald TM.
Curr Atheroscler Rep (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease.
Ripa RS; Kjaer A; Hesse B.
Curr Atheroscler Rep (Unknown)
Published: 2014
1/6 Transparent
Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.
Bays H.
Curr Atheroscler Rep (Unknown)
Published: 2014
1/6 Transparent
GPR109A and vascular inflammation.
Chai JT; Digby JE; Choudhury RP.
Curr Atheroscler Rep (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Oxidized PLs and vascular inflammation.
Aldrovandi M; O'Donnell VB.
Curr Atheroscler Rep (Unknown)
Published: 2013
1/6 Transparent
Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation.
Hadoke PW; Kipari T; Seckl JR; Chapman KE.
Curr Atheroscler Rep (Unknown)
Published: 2013
1/6 Transparent
Sortilin as a regulator of lipoprotein metabolism.
Strong A; Rader DJ.
Curr Atheroscler Rep (Unknown)
Published: 2012
1/6 Transparent
Molecular pathways regulating macrophage polarization: implications for atherosclerosis.
Hoeksema MA; Stöger JL; de Winther MP.
Curr Atheroscler Rep (Unknown)
Published: 2012
1/6 Transparent
Diabetes and hypertension: is there a common metabolic pathway?
Cheung BM; Li C.
Curr Atheroscler Rep (Unknown)
Published: 2012
2/6 Transparent
Funding Declared
Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.
Troll JG.
Curr Atheroscler Rep (Unknown)
Published: 2011
1/6 Transparent
The anti-ischemic and anti-anginal properties of statins.
Lardizabal JA; Deedwania PC.
Curr Atheroscler Rep (Unknown)
Published: 2011
1/6 Transparent
Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?
Devaraj S; Siegel D; Jialal I.
Curr Atheroscler Rep (Unknown)
Published: 2011
2/6 Transparent
Funding Declared
Alpha-linolenic acid: is it essential to cardiovascular health?
Geleijnse JM; de Goede J; Brouwer IA.
Curr Atheroscler Rep (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients.
Siri-Tarino PW; Sun Q; Hu FB; Krauss RM.
Curr Atheroscler Rep (Unknown)
Published: 2010
1/6 Transparent
Recent advances in childhood arterial ischemic stroke.
Fox CK; Fullerton HJ.
Curr Atheroscler Rep (Unknown)
Published: 2010
Soluble epoxide hydrolase in atherosclerosis.
Wang YX; Ulu A; Zhang LN; Hammock B.
Curr Atheroscler Rep (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Genetic variants of the Renin Angiotensin system: effects on atherosclerosis in experimental models and humans.
Daugherty A; Poduri A; Chen X; Lu H; Cassis LA.
Curr Atheroscler Rep (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.
Devaraj S; Valleggi S; Siegel D; Jialal I.
Curr Atheroscler Rep (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Lipidomics: a tool for studies of atherosclerosis.
Ekroos K; Jänis M; Tarasov K; Hurme R; Laaksonen R.
Curr Atheroscler Rep (Unknown)
Published: 2010
1/6 Transparent